HOME >> BIOLOGY >> NEWS
Researchers begin promising new trial to fight colorectal cancer

NEW YORK, March 10, 2004 New York University School of Medicine investigators are leading a national study, called TREE-2, which will evaluate the safety and efficacy of three regimens of Eloxatin™ plus fluoropymidine, plus Avastin™ as first-line treatment of patients with advanced colorectal cancer. Two hundred and ten patients will be enrolled at 80 sites in the United States.

This new study is based on promising data presented at the 2003 American Society of Clinical Oncology (ASCO) meeting demonstrating an incremental survival benefit when Avastin™ was added to a standard first-line colon cancer treatment regimen called IFL (Irinotecan, 5-FU, Leucovorin). At the same meeting, it was reported that patients treated with Eloxatin, used in combination with the fluoropymidine 5-FU (FOLFOX), survived longer than those treated with IFL in a head-to-head comparison study. Eloxatin? is manufactured by Sanofy-Synthelabo and Genentech manufactures Avastin?.

"The findings from this study have the potential to affect the standard of care for metastatic colorectal cancer," said Howard Hochster, M.D, lead investigator of the TREE 2 study. "We are making focused efforts to find the most effective therapeutic option currently available for treatment of colorectal cancer. This study will combine an effective anti-angiogenesis antibody with the best possible chemotherapy. We are also looking at ways of making the oxaliplatin-based chemotherapy regimens more user friendly for the patient."

It is hoped that this new drug regimen will ultimately improve the treatment and survival rate of patients with colorectal cancer, the second leading cause of cancer deaths in the United States. Approximately 150,000 new cases are diagnosed each year and in 2003 nearly 60,000 deaths were attributed to the disease.


'"/>

Contact: Pam Mcdonnell
Pam.mcdonnell@med.nyu.edu
212-404-3555
New York University Medical Center and School of Medicine
10-Mar-2004


Page: 1

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: